ORIGINAL ARTICLE |
|
Year : 2016 | Volume
: 2
| Issue : 1 | Page : 20-23 |
|
Seroprevalence of hepatitis B and C in patients on hemodialysis and their antibody response to hepatitis B vaccination
Anandh Perumal1, Philip Vivian Joseph Ratnam1, Shashikala Nair1, Patricia Anitha1, Veerappan Illangovan2, Reba Kanungo1
1 Department of Microbiology, Pondicherry Institute of Medical Sciences, Puducherry, India 2 Division of Nephrology, K. G. Hospital, Coimbatore, Tamil Nadu, India
Correspondence Address:
Philip Vivian Joseph Ratnam Department of Microbiology, Pondicherry Institute of Medical Sciences, Kalapet, Puducherry - 605 014 India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2455-3069.184119
|
|
Introduction: Hepatitis B and C viral (HBV and HCV) infections are the most common infections acquired by hemodialysis (HD) patients. The prevalence of HBV and HCV infections in dialysis patients in India is 3.4-43% and 20-80%, respectively. This study was carried out to find out the current prevalence rate of HBV and HCV infections in HD patients in Puducherry.
Materials and Methods: Serum samples from 65 patients with chronic kidney disease, who were admitted to a tertiary care hospital for HD, were screened for hepatitis B surface antigen (HBsAg) and HCV antibodies. The samples were collected on the first visit to the center before starting the dialysis and thereafter periodically. The serological results were correlated with gender, age, and duration of disease. An attempt was made to correlate the evidence of viral infection with clinical evidence of hepatitis, liver profile, and history of any transfusions in the past 3 years.
Results: Among the 65 patients, 14 individuals were found be infected with hepatitis, HBV (5), and HCV (10) accounting for 22%. A single individual was coinfected with both the virus. There was a male preponderance accounting for 77% of patients on dialysis. Hepatitis B vaccination was given to all HBsAg negative patients (77%). Two of the vaccinated individuals were infected with HCV.
Conclusions: Further studies are required to determine risk factors and factors that determine why some escape infection for prolonged periods. Hepatitis B vaccination should be mandatory for individuals undergoing HD. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|